Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Biomarkers in Alzheimer's disease].

Revista de neurologia - 1 Apr 2014

García-Ribas G, López-Sendón Moreno J L, García-Caldentey J

Abstract excerpt

The new diagnostic criteria for Alzheimer's disease (AD) include brain imaging and cerebrospinal fluid (CSF) biomarkers, with the aim of increasing the certainty of whether a patient has an ongoing AD neuropathologic process or not. Three CSF biomarkers, Aß42, total tau, and phosphorylated tau, reflect the core pathological features of AD. It is already known that these pathological processes of AD starts decades...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Apolipoprotein E4
Share to Cognition Disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Diagnosis, Differential

Share to Early Diagnosis

Share to Presenilin-1

Share to tau Proteins

Source

Identifiers

PMID: 24677154

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Biomarkers in Alzheimer's disease].PMID 24677154Read ↗

Emerging Biomarkers for Early Detection of Alzheimer’s Disease: A Systematic ReviewSemantic proximity Read ↗

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent InsightsSemantic proximity Read ↗

[Cerebrospinal fluid markers in early diagnosis of Alzheimer dementia].Semantic proximity Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

Biomarkers for Alzheimer's disease.Semantic proximity Read ↗

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read ↗

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Semantic proximity Read ↗

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.Semantic proximity Read ↗

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADSemantic proximity Read ↗

Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.Semantic proximity Read ↗

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?Semantic proximity Read ↗

Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.